DEXCOM, INC. SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense
DEXCOM, INC. (DXCM) reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense of $3.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense · last filed 2026-02-12
- DEXCOM, INC. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2025 was $3.30M.
- DEXCOM, INC. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2024 was -$100.00K, a 105.00% decline from fiscal 2023.
- DEXCOM, INC. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2023 was $2.00M, a 16.67% decline from fiscal 2022.
- DEXCOM, INC. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2022 was $2.40M.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 12 month | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 12 month as first filed |
|---|---|---|
| 2025-12-31 | $3.30M 10-K · filed 2026-02-12 | |
| 2024-12-31 | -$100.00K 10-K · filed 2026-02-12 | |
| 2023-12-31 | $2.00M 10-K · filed 2026-02-12 | |
| 2022-12-31 | $2.40M 10-K · filed 2025-02-18 | |
| 2021-12-31 | -$1.40M 10-K · filed 2024-02-08 | |
| 2020-12-31 | $3.20M 10-K · filed 2023-02-09 | |
| 2019-12-31 | $900.00K 10-K · filed 2022-02-14 | |
| 2018-12-31 | $3.60M 10-K · filed 2021-02-11 | |
| 2017-12-31 | $5.30M 10-K · filed 2020-02-13 | |
| 2016-12-31 | $9.50M 10-K · filed 2019-02-21 | |
| 2015-12-31 | $7.80M 10-K · filed 2018-02-27 | |
| 2014-12-31 | $4.00M 10-K · filed 2017-02-28 | |
| 2013-12-31 | $2.70M 10-K · filed 2016-02-23 | |
| 2012-12-31 | $1.20M 10-K · filed 2015-02-25 | |
| 2011-12-31 | $700.00K 10-K · filed 2014-02-20 | $733.00K 10-K · filed 2012-02-23 |
| 2010-12-31 | $700.00K 10-K · filed 2013-02-21 | $658.00K 10-K · filed 2012-02-23 |
| 2009-12-31 | $356.00K 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |